The Infinite Loop by Nebius reports on the rise of AI transcription bots, evolving from note-takers to meeting assistants, with market growth projected to reach $19.2 billion by 2034.

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

In order to meet the rapidly increasing demand for item pools for large-scale assessments, automatic item generation (AIG) emerged about thirty years ago, using pre-programmed algorithms to ...

For reference, please review the following policies and guidelines. As you prepare your submission to the Meeting, please make note of the following author and sponsorship eligibility criteria: ...

HOUSTON, TX, October 23, 2025 (EZ Newswire) -- Inception Fertility, opens new tab™ (Inception), the largest provider of comprehensive fertility products and services in North America, announces today ...

Around one in seven biomedical-research abstracts published last year was probably written with the help of artificial intelligence (AI), according to a massive analysis 1 of the scholarly literature.

Scientists show that the frequency of a set of words seems to have increased in published study abstracts since ChatGPT was released into the world. By Gina Kolata Scientists know it is happening, ...

NeoACTIVATE arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable stage III melanoma. A first-in-human study of DYP688, an antibody drug conjugate delivering a ...

After spending 2024 cycling through different looks before reverting to the original for some reason, Google Messages has widely rolled out a redesign of the text field. This pill-shaped text field is ...

Wall-to-wall books tell an interior design story without saying a word Completed in 2011, the Stuttgart City Library is one of the country’s most photographed locations. Smithsonian Photo Contest ...

Michigan Sen. Elissa Slotkin in her brief Democratic response to President Trump's joint address to Congress warned that Mr. Trump, in the his first few weeks of his second presidential term, has ...

Whether fixed-duration acalabrutinib–venetoclax (with or without obinutuzumab) would result in better progression-free survival than chemoimmunotherapy in patients with untreated chronic lymphocytic ...